{"id":"https://openalex.org/W4280628241","doi":"https://doi.org/10.1158/1538-7445.evodyn22-b012","title":"Abstract B012: Impact of stromal protection on in-vivo response to ALK targeted therapies in NSCLC","display_name":"Abstract B012: Impact of stromal protection on in-vivo response to ALK targeted therapies in NSCLC","publication_year":2022,"publication_date":"2022-05-15","ids":{"openalex":"https://openalex.org/W4280628241","doi":"https://doi.org/10.1158/1538-7445.evodyn22-b012"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.evodyn22-b012","doi":"https://doi.org/10.1158/1538-7445.evodyn22-b012","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.evodyn22-b012","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010829737","display_name":"Bina Desai","orcid":"https://orcid.org/0000-0003-0454-7583","observed_orcids":["https://orcid.org/0000-0003-0454-7583"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bina Desai","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078508762","display_name":"Viktoriya Marusyk","orcid":"https://orcid.org/0009-0004-5736-1365","observed_orcids":["https://orcid.org/0009-0004-5736-1365"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Viktoriya Marusyk","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023455221","display_name":"Daria Miroshnychenko","orcid":"https://orcid.org/0000-0001-6425-5000","observed_orcids":["https://orcid.org/0000-0001-6425-5000"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daria Miroshnychenko","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069263867","display_name":"Chandler Gatenbee","orcid":"https://orcid.org/0000-0002-9730-5964","observed_orcids":["https://orcid.org/0000-0002-9730-5964"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chandler Gatenbee","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012452779","display_name":"Uwe Rix","orcid":"https://orcid.org/0000-0002-8242-2770","observed_orcids":["https://orcid.org/0000-0002-8242-2770"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Uwe Rix","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069501174","display_name":"Alexander R.A. Anderson","orcid":"https://orcid.org/0000-0002-2536-4383","observed_orcids":["https://orcid.org/0000-0002-2536-4383"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Anderson","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064494204","display_name":"Eric B. Haura","orcid":"https://orcid.org/0000-0003-3114-1909","observed_orcids":["https://orcid.org/0000-0003-3114-1909"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Haura","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009118439","display_name":"Andriy Marusyk","orcid":"https://orcid.org/0000-0002-0087-9575","observed_orcids":["https://orcid.org/0000-0002-0087-9575"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andriy Marusyk","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I3019308854"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"10_Supplement","first_page":"B012","last_page":"B012"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8740000128746033},{"id":"https://openalex.org/keywords/anaplastic-lymphoma-kinase","display_name":"anaplastic lymphoma kinase","score":0.6489999890327454},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9010000228881836},{"id":"https://openalex.org/keywords/alectinib","display_name":"alectinib","score":0.8740000128746033},{"id":"https://openalex.org/keywords/cancer-associated-fibroblasts","display_name":"cancer-associated fibroblasts","score":0.8999999761581421},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8610000014305115},{"id":"https://openalex.org/keywords/hepatocyte-growth-factor","display_name":"hepatocyte growth factor","score":0.9829999804496765},{"id":"https://openalex.org/keywords/c-met","display_name":"c-Met","score":0.9330000281333923},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.7770000100135803},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.781000018119812},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.753000020980835},{"id":"https://openalex.org/keywords/co-culture","display_name":"co-culture","score":0.49399998784065247},{"id":"https://openalex.org/keywords/conditioned-medium","display_name":"conditioned medium","score":0.6970000267028809},{"id":"https://openalex.org/keywords/alk-positive-tumors","display_name":"ALK-positive tumors","score":0.38999998569488525},{"id":"https://openalex.org/keywords/targeted-therapy-response","display_name":"targeted therapy response","score":0.32100000977516174}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6915673017501831},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.677513837814331},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6298662424087524},{"id":"https://openalex.org/C117643217","wikidata":"https://www.wikidata.org/wiki/Q17824987","display_name":"Anaplastic lymphoma kinase","level":4,"score":0.5643911361694336},{"id":"https://openalex.org/C7876069","wikidata":"https://www.wikidata.org/wiki/Q14873666","display_name":"Paracrine signalling","level":3,"score":0.563873827457428},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5468040704727173},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5428892970085144},{"id":"https://openalex.org/C2776996007","wikidata":"https://www.wikidata.org/wiki/Q2399112","display_name":"Hepatocyte growth factor","level":3,"score":0.5084720849990845},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5031513571739197},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.44428128004074097},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.43653783202171326},{"id":"https://openalex.org/C2909706936","wikidata":"https://www.wikidata.org/wiki/Q42417562","display_name":"Cancer-Associated Fibroblasts","level":4,"score":0.4249686598777771},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.41517624258995056},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.350097119808197},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2914735674858093},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2796023488044739},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20621055364608765},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.09086757898330688},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07220330834388733},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.evodyn22-b012","doi":"https://doi.org/10.1158/1538-7445.evodyn22-b012","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.evodyn22-b012","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282928996","https://openalex.org/W4380079085","https://openalex.org/W3135763893","https://openalex.org/W4395452825","https://openalex.org/W7116954969","https://openalex.org/W4401937067","https://openalex.org/W4385409873","https://openalex.org/W7221263580","https://openalex.org/W2982420024","https://openalex.org/W4411352726"],"abstract_inverted_index":{"Abstract":[0],"Lung":[1],"cancer":[2,12,108],"accounts":[3],"for":[4,43],"most":[5,15],"cancer-related":[6],"death":[7],"worldwide.":[8],"Non-small":[9],"cell":[10],"lung":[11,20],"(NSCLC)":[13],"is":[14,155,165],"prominent":[16],"histological":[17],"subtype":[18],"of":[19,24,29,38,69,75,84,89,105,118,135,147,162,174,185,215,224,238,248,250,266,318,324,340,399,426,441],"cancer.":[21],"About":[22],"5-7%":[23],"NSCLC":[25,437],"shows":[26],"constitutive":[27],"activation":[28],"oncogenic":[30],"anaplastic":[31],"lymphoma":[32],"kinase":[33],"(ALK).":[34],"Though":[35],"clinical":[36],"introduction":[37],"tyrosine":[39],"kinases":[40],"inhibitors":[41],"(TKIs)":[42],"ALK,":[44],"has":[45],"improved":[46],"patient":[47],"survival,":[48],"it":[49],"did":[50],"not":[51,359],"translate":[52],"into":[53],"cures":[54],"as":[55,114,200,202],"acquired":[56],"resistance":[57],"inevitably":[58],"emerges":[59],"in":[60,176,259,277,284,301,351,436,450],"patients":[61],"with":[62,192,221,287],"advanced":[63],"and":[64,141,281,381,386,452],"metastatic":[65],"cancers.":[66],"While":[67,144],"some":[68],"the":[70,90,115,133,145,160,172,222,236,269,305,397,442,447],"tumor":[71,91,106,151,189,208,242,302,341],"cells":[72,92,152,209,243],"are":[73,370],"capable":[74],"surviving":[76],"therapy":[77],"due":[78],"to":[79,86,149,178,241,253,268,291,361,365,396,432,454],"their":[80],"intrinsic":[81],"characteristics,":[82],"inability":[83,249],"therapies":[85,435],"eliminate":[87],"all":[88],"also":[93,364],"reflects":[94],"a":[95,101],"contribution":[96],"by":[97,137],"microenvironmental":[98],"factors.":[99],"As":[100],"major":[102],"cellular":[103],"component":[104],"microenvironment,":[107],"associated":[109],"fibroblasts":[110],"(CAFs)":[111],"have":[112,124],"emerged":[113],"key":[116],"determinant":[117],"environmental":[119],"protection.":[120],"Many":[121],"in-vitro":[122,217,293],"studies":[123,195],"demonstrated":[125],"that":[126,198,314,355],"CAF-produced":[127],"paracrine":[128],"factors":[129],"can":[130,357],"dramatically":[131],"blunt":[132],"effect":[134],"TKIs":[136],"providing":[138],"alternative":[139],"mitogenic":[140],"survival":[142],"signals.":[143],"ability":[146],"CAFs":[148,186,206],"protect":[150],"from":[153,187,205,230],"TKI":[154],"well":[156,201],"documented":[157],"in-vitro,":[158],"whether":[159],"impact":[161,173,237],"stromal":[163,331,378,387,427],"protection":[164,216,240,332,347,379,428],"relevant":[166],"in-vivo":[167,430],"remains":[168],"unresolved.":[169],"To":[170,234],"study":[171,235],"CAF":[175,232],"response":[177,265,431],"ALK":[179,211,271,433],"TKI,":[180],"we":[181,196,245,263,296,312],"isolated":[182],"multiple":[183],"derivatives":[184],"patient\u2019s":[188],"resections.":[190],"Consistent":[191],"previously":[193],"reported":[194],"observed":[197,297],"co-culture":[199],"conditioned":[203],"media":[204],"protects":[207],"against":[210,404],"TKIs.":[212],"This":[213],"degree":[214],"was":[218,335,348],"highly":[219],"correlated":[220],"level":[223],"hepatocyte":[225],"growth":[226],"factor":[227],"(HGF)":[228],"measured":[229],"each":[231],"isolates.":[233],"HGF-mediated":[239],"in-vivo,":[244,321,380],"took":[246],"advantage":[247],"murine":[251],"HGF":[252,329],"activate":[254],"its":[255],"unique":[256],"receptor":[257],"cMET":[258],"human":[260],"cells.":[261],"Specifically,":[262],"compared":[264],"tumors":[267,275],"frontline":[270],"TKI:":[272],"alectinib":[273],"between":[274,304,384],"growing":[276],"regular":[278],"NSG":[279,285],"xenografts":[280],"those":[282],"grown":[283],"derivate":[286],"humanized":[288],"HGF.":[289],"Contrary":[290],"our":[292],"based":[294],"expectations,":[295],"only":[298,360],"minor":[299],"differences":[300,326],"responses":[303],"two":[306],"strains.":[307],"Using":[308],"spatial":[309],"histology":[310],"analyses,":[311],"found":[313],"rather":[315],"than":[316],"irrelevance":[317],"HGF-cMET":[319],"axis":[320],"this":[322,346],"lack":[323],"substantial":[325],"reflected":[327],"strong":[328],"independent":[330],"effect,":[333],"which":[334],"maintained":[336],"through":[337],"different":[338],"phases":[339],"responses,":[342],"including":[343],"relapse.":[344],"Surprisingly,":[345],"partially":[349],"retained":[350],"relapsing":[352],"tumors,":[353],"suggesting":[354],"stroma":[356],"contribute":[358],"persistence,":[362],"but":[363],"resistance.":[366,388],"Our":[367],"ongoing":[368],"efforts":[369],"focused":[371],"on":[372,382,429,446],"determining":[373],"what":[374],"molecular":[375],"mechanisms":[376],"underlying":[377],"interplay":[383],"cell-intrinsic":[385],"Addressing":[389],"these":[390],"questions":[391],"will":[392],"provide":[393],"knowledge":[394],"necessary":[395],"development":[398],"more":[400],"effective":[401],"therapeutic":[402],"strategies":[403],"ALK+":[405],"NSCLC.":[406],"Citation":[407],"Format:":[408],"Bina":[409],"Desai,":[410],"Viktoriya":[411],"Marusyk,":[412],"Daria":[413],"Miroshnychenko,":[414],"Chandler":[415],"Gatenbee,":[416],"Uwe":[417],"Rix,":[418],"Alexander":[419],"Anderson,":[420],"Eric":[421],"Haura,":[422],"Andriy":[423],"Marusyk.":[424],"Impact":[425],"targeted":[434],"[abstract].":[438],"In:":[439],"Proceedings":[440],"AACR":[443],"Special":[444],"Conference":[445],"Evolutionary":[448],"Dynamics":[449],"Carcinogenesis":[451],"Response":[453],"Therapy;":[455],"2022":[456],"Mar":[457],"14-17.":[458],"Philadelphia":[459],"(PA):":[460],"AACR;":[461],"Cancer":[462],"Res":[463],"2022;82(10":[464],"Suppl):Abstract":[465],"nr":[466],"B012.":[467]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2022-05-22T00:00:00"}